FDA Asks Drug Companies To Assess Cholesterol Drug's Cognitive Risks
Category: WELLNESS
Amgen, which has said it could file for regulatory approval of PCSK9 drug evolocumab this year, said it has been proactively
By Reuters, Reuters, 2014-03-07